Health Products

ACCESS SYSTEM & UNICEL DXI 600/800 ACCESS IMMUNOASSAY SYSTEM - UNCONJUGATED ESTRIOL ASSAY (2020-08-31)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameModel or catalog number
921133
Manufacturer
Beckman Coulter, Inc.
250 S. Kraemer Blvd.
Brea
92821
California
UNITED STATES
B. UNICEL DXI 600 ACCESS IMMUNOASSAY SYSTEM - UNCONJUGATED ESTRIOL ASSAY33570
921133
Manufacturer
Beckman Coulter, Inc.
250 S. Kraemer Blvd.
Brea
92821
California
UNITED STATES
C. UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM - UNCONJUGATED ESTRIOL ASSAY33570
921133
Manufacturer
Beckman Coulter, Inc.
250 S. Kraemer Blvd.
Brea
92821
California
UNITED STATES
A. ACCESS SYSTEM - UNCONJUGATED ESTRIOL ASSAY33570

Introduction

Affected Products

A. ACCESS SYSTEM - UNCONJUGATED ESTRIOL ASSAY

B. UNICEL DXI 600 ACCESS IMMUNOASSAY SYSTEM - UNCONJUGATED ESTRIOL ASSAY

C. UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM - UNCONJUGATED ESTRIOL ASSAY

Reason

Customer feedback has helped Beckman Coulter identify and characterize the potential for higher than expected Bovine-ALP associated interference in patient samples tested with the access uE3 assay, for the affected lots. An internal investigation of ~300 samples confirmed that up to 3% of patient samples may demonstrate Bovine-ALP associated interference. The frequency and mechanism of Bovine-ALP associated interference is specific to the access uE3 assay. This interference is not associated with patient sample endogenous ALP levels.

Based on the internal investigation performed on ~300 samples, Bovine-ALP associated interference could increase serum sample uE3 concentrations by:
  • a mean of 50% (range 33%-77%) in samples with uE3 concentrations >1.5 ng/mL.
  • a mean of 0.53 ng/mL (range 0.42-0.70 ng/mL) in samples with uE3 concentrations ?1.5 ng/mL.


A falsely elevated uE3 test result can lead to inaccurately classifying the relative risk of chromosomal anomalies-such as trisomy 21 and 18-in patient samples undergoing triple and quad prenatal screening.

Second trimester prenatal screening includes Alpha-fetoprotein (AFP), Human chorionic gonadotropin (hCG), unconjugated estriol (uE3) and inhibin A. Only uE3 is affected by the issue.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime